S

Sironax

23 employees

Sironax is a clinical-stage biotechnology company that develops novel products and treatments for age-related degenerative diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Neurosciences
Health Care
Degenerative diseases
Therapeutics
Pharmaceutical
Inflammatory diseases

Date founded

2017

Funding rounds raised

Total raised

$200M

from 6 investors over 6 rounds

S

Sironax raised $200M on August 2, 2022

Investors: K2 Venture Capital, -, The Invus Group, MSA Capital and Temasek

S

Sironax raised $101M on September 1, 2019

Investors: F-Prime Capital Partners

FAQ